The global AI in Animal Health market reached a valuation of USD 901.81 Million in 2022, with a projected CAGR of 11.13% by 2028, expecting to reach USD 1688.54 Million. The market’s growth is driven by AI’s ability to detect diseases early, enhance disease management and veterinary practices, and revolutionise animal health management using predictive analytics. Challenges include data privacy concerns and training for veterinarians.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
